Hi @Milly21 BCNA acknowledges the significant cost of tests such as oncotype dx testing. It has been a key issue on our advocacy agenda for many years and BCNA will continue efforts to make this test (or a similar test such as mammaprint) available and affordable for women. Please see the most recent item on our website discussing this issue in the link below:
https://www.bcna.org.au/news/2018/06/new-research-findings-confirm-the-benefit-of-the-oncotype-dx-tumour-profiling-test/